Millstone Medical Outsourcing Breaks Ground on Clean Room Facility Expansion at Headquarters
Millstone Medical Outsourcing announces the groundbreaking for a third cleanroom facility expansion at its Fall River, MA headquarters.
Millstone Medical Outsourcing announces the groundbreaking for a third cleanroom facility expansion at its Fall River, MA headquarters.
ILC Doveror specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced the launch of Water for Injection (WFI) for the biotherapeutics market.
SK pharmteco, is pleased to announce $35m investment for the initial phase of an expansion plan for SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant.
Pfizer Inc. has planned a $120 million investment at its Kalamazoo manufacturing facility to support the production of its COVID-19 antiviral treatment, Paxlovid.
Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, has announced completion of additions to its research capacity and services
The CGMP facility represents a critical first step in a new era of drug manufacturing aimed at strengthening domestic supply chain resiliency
Sartorius will expand its capacities for production, innovation, and storage at its French facilities in Aubagne, Cergy and Lourdes in order to meet the strong demand of the biopharmaceutical industry
Vaxess Technologies celebrates the grand opening of their 3,600 square feet pilot GMP manufacturing facility on Monday.
ClorDiSys ultraviolet light (UV-C) methodology and equipment is the first practical approach to improving the situation. These solutions allow for the safer transfer of items into a clean-room, disinfecting incoming pallets, supplies, and equipment, or simply disinfecting communal spaces after use.
Altasciences today announced the continued expansion of their formulation, manufacturing, and analytical services facilities in Philadelphia, PA.
Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company seeking to improve lives through the curative potential of gene therapies, announced the opening of its state-of-the-art manufacturing facility at the Phase II Suzhou Biomedical Industrial Park (BioBAY) in Suzhou, China.